InvestorsHub Logo
Followers 1
Posts 219
Boards Moderated 0
Alias Born 03/09/2006

Re: rod5247 post# 4309

Wednesday, 01/10/2007 1:28:34 PM

Wednesday, January 10, 2007 1:28:34 PM

Post# of 6490
<Tercica made a big and repetitive point in the court proceedings that short stature was the only indication approved for Iplex. They also made a point of this in post trial motions. Now Iplex is being used in Italy at government request under a EU license.>

Re your arrogant reply to Dew, if you were not insinuating that Iplex for ALS is now as good as an approved application in Italy, then why did you you even make the above statement. The proof is in your use of "a EU license" instead of accurately stating that the license is granted by Cephalon (a U.S. company located in Frazer, PA).

And, if "clarity will come in time", why do you have the need to "clarify" the news that "is what it is"? You are apparently playing word games to suit your own agenda.

Is that enough factual information to "explain my disagreement" with your post which is loaded with speculation and information that is not factual.

Now you can delete it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News